Zhuhai Rundu Pharmaceutical Co., Ltd.
SZSE:002923.SZ
12.55 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2015 Q2 | 2015 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 277.34 | 291.072 | 306.094 | 346.522 | 289.928 | 296.078 | 359.359 | 380.255 | 333.113 | 336.147 | 322.719 | 327.431 | 287.967 | 250.431 | 324.097 | 294.3 | 303.163 | 337.412 | 317.755 | 340.829 | 328.324 | 350.052 | 340.703 | 293.323 | 273.545 | 254.82 | 222.172 | 219.833 | 186.716 | 186.989 | 185.884 | 177.571 | 168.574 | 140.696 | 140.696 |
Cost of Revenue
| 163.706 | 152.679 | 153.972 | 174.515 | 148.101 | 131.651 | 184.496 | 159.89 | 154.449 | 148.679 | 137.771 | 124.626 | 116.449 | 88.708 | 129.053 | 117.665 | 115.136 | 112.976 | 115.107 | 100.576 | 89.654 | 93.175 | 96.559 | 66.579 | 62.262 | 64.324 | 67.099 | 61.565 | 72.091 | 62.621 | 79.381 | 64.185 | 63.028 | 43.904 | 43.904 |
Gross Profit
| 113.634 | 138.394 | 152.122 | 172.008 | 141.827 | 164.427 | 174.863 | 220.365 | 178.664 | 187.468 | 184.948 | 202.806 | 171.518 | 161.723 | 195.044 | 176.635 | 188.027 | 224.436 | 202.648 | 240.253 | 238.67 | 256.876 | 244.145 | 226.744 | 211.283 | 190.496 | 155.074 | 158.267 | 114.624 | 124.367 | 106.503 | 113.386 | 105.546 | 96.792 | 96.792 |
Gross Profit Ratio
| 0.41 | 0.475 | 0.497 | 0.496 | 0.489 | 0.555 | 0.487 | 0.58 | 0.536 | 0.558 | 0.573 | 0.619 | 0.596 | 0.646 | 0.602 | 0.6 | 0.62 | 0.665 | 0.638 | 0.705 | 0.727 | 0.734 | 0.717 | 0.773 | 0.772 | 0.748 | 0.698 | 0.72 | 0.614 | 0.665 | 0.573 | 0.639 | 0.626 | 0.688 | 0.688 |
Reseach & Development Expenses
| 37.774 | 34.871 | 24.954 | 51.644 | 34.41 | 23.335 | 20.054 | 33.335 | 18.733 | 21.907 | 21.615 | 31.165 | 21.34 | 20.807 | 18.828 | 31.173 | 22.78 | 24.423 | 24.09 | 33.83 | 22.975 | 22.973 | 34.763 | 24.175 | 19.365 | 34.303 | 10.662 | 44.693 | 0 | 16.534 | 0 | 0 | 0 | 4.002 | 4.002 |
General & Administrative Expenses
| 0 | -6.593 | 19.267 | -29.704 | 45.168 | -0.492 | 15.404 | -25.899 | 40.744 | -3.507 | 12.261 | -43.381 | 46.597 | -3.719 | 15.743 | -14.531 | 23.626 | 0.085 | 19.603 | -8.581 | 25.683 | 8.175 | 10.766 | -56.718 | 32.194 | -10.806 | 28.873 | -23.103 | 17.396 | -9.554 | 17.306 | 0 | 0 | 11.216 | 11.216 |
Selling & Marketing Expenses
| 0 | 63.329 | 69.227 | 58.468 | 87.304 | 85.743 | 83.114 | 75.58 | 101.341 | 103.436 | 109.195 | 106.058 | 98.409 | 93.405 | 118.782 | 85.982 | 103.409 | 130.26 | 121.338 | 169.472 | 153.942 | 173.115 | 165.04 | 177.629 | 146.463 | 138.337 | 101.338 | 102.682 | 69.235 | 73.046 | 66.98 | 0 | 0 | 62.331 | 62.331 |
SG&A
| 80.575 | 56.736 | 88.493 | 28.764 | 132.472 | 85.251 | 98.518 | 49.681 | 142.085 | 99.929 | 121.456 | 62.677 | 145.006 | 89.686 | 134.525 | 71.452 | 127.035 | 130.346 | 140.941 | 160.891 | 179.625 | 181.29 | 175.806 | 120.911 | 178.657 | 127.531 | 130.211 | 25.797 | 86.631 | 63.492 | 84.286 | 0 | 0 | 73.546 | 73.546 |
Other Expenses
| -0.773 | -0.046 | -0.2 | -0.366 | -0.287 | -0.153 | -0.006 | 43.952 | -20.878 | 21.192 | 0.029 | -0.091 | -1.704 | -0.122 | -0.131 | -3.433 | -0.978 | -0.137 | -0.202 | -0.571 | -0.159 | -0.212 | -0.169 | 0.073 | 1.036 | -0.195 | -1.04 | -4.29 | 0.162 | -1.018 | 4.034 | -92.592 | -82.383 | 0 | 0 |
Operating Expenses
| 119.122 | 114.011 | 112.975 | 126.56 | 143.542 | 122.613 | 118.566 | 126.968 | 139.941 | 143.028 | 143.1 | 143.374 | 142.904 | 131.89 | 153.141 | 142.439 | 147.293 | 177.819 | 164.709 | 221.716 | 200.716 | 217.726 | 210.232 | 206.253 | 179.172 | 158.434 | 130.454 | 127.227 | 88.972 | 87.875 | 86.525 | -92.592 | -82.383 | 74.989 | 74.989 |
Operating Income
| -5.488 | 10.833 | 33.728 | 7.124 | -4.715 | 36.137 | 47.721 | 65.269 | 31.863 | 42.645 | 41.578 | 54.025 | 29.334 | 30.333 | 40.093 | 28.739 | 38.955 | 49.073 | 36.815 | 19.061 | 40.46 | 41.894 | 32.137 | 25.359 | 33.181 | 35.657 | 25.645 | 29.414 | 23.045 | 34.456 | 17.049 | 20.794 | 23.162 | 21.3 | 21.3 |
Operating Income Ratio
| -0.02 | 0.037 | 0.11 | 0.021 | -0.016 | 0.122 | 0.133 | 0.172 | 0.096 | 0.127 | 0.129 | 0.165 | 0.102 | 0.121 | 0.124 | 0.098 | 0.128 | 0.145 | 0.116 | 0.056 | 0.123 | 0.12 | 0.094 | 0.086 | 0.121 | 0.14 | 0.115 | 0.134 | 0.123 | 0.184 | 0.092 | 0.117 | 0.137 | 0.151 | 0.151 |
Total Other Income Expenses Net
| 2.232 | -0.046 | -6.276 | -59.835 | -0.287 | -0.153 | 0.579 | -0.036 | -0.294 | -0.254 | 0.17 | -0.091 | -0.984 | 0.378 | -1.941 | -8.89 | -2.758 | 2.319 | -1.326 | -0.047 | 2.348 | 2.532 | -1.945 | 4.941 | 2.105 | 3.4 | -0.015 | 257.456 | -91.418 | -4.094 | 1.105 | 234.9 | -79.84 | 0.227 | 0.227 |
Income Before Tax
| -3.257 | 10.787 | 33.528 | 6.758 | -5.002 | 35.984 | 48.3 | 65.233 | 31.568 | 42.391 | 41.748 | 53.934 | 27.63 | 30.211 | 39.962 | 25.305 | 37.977 | 48.936 | 36.613 | 18.49 | 40.301 | 41.682 | 31.968 | 25.432 | 34.217 | 35.462 | 24.605 | 25.124 | 23.206 | 32.398 | 21.083 | 21.382 | 25.706 | 21.527 | 21.527 |
Income Before Tax Ratio
| -0.012 | 0.037 | 0.11 | 0.02 | -0.017 | 0.122 | 0.134 | 0.172 | 0.095 | 0.126 | 0.129 | 0.165 | 0.096 | 0.121 | 0.123 | 0.086 | 0.125 | 0.145 | 0.115 | 0.054 | 0.123 | 0.119 | 0.094 | 0.087 | 0.125 | 0.139 | 0.111 | 0.114 | 0.124 | 0.173 | 0.113 | 0.12 | 0.152 | 0.153 | 0.153 |
Income Tax Expense
| -2.636 | 2.042 | 4.472 | 5.418 | -1.308 | 7.164 | 7.868 | 11.379 | 5.04 | 5.42 | 3.624 | 2.761 | 3.619 | 0.672 | 4.918 | 0.29 | 3.495 | 4.543 | 4.641 | -1.823 | 7.036 | 5.351 | 2.981 | -0.554 | 5.539 | 3.242 | 4.645 | 3.061 | 0.892 | 4.546 | 2.66 | 236.849 | -78.799 | 3.231 | 3.231 |
Net Income
| -0.621 | 8.746 | 29.056 | 1.341 | -3.694 | 28.82 | 40.432 | 53.854 | 26.528 | 36.971 | 38.124 | 51.173 | 24.011 | 29.539 | 35.044 | 25.016 | 34.482 | 44.393 | 31.972 | 20.313 | 33.265 | 36.332 | 28.987 | 25.986 | 28.678 | 32.22 | 19.96 | 22.063 | 22.314 | 27.852 | 18.423 | 18.845 | 22.121 | 18.296 | 18.296 |
Net Income Ratio
| -0.002 | 0.03 | 0.095 | 0.004 | -0.013 | 0.097 | 0.113 | 0.142 | 0.08 | 0.11 | 0.118 | 0.156 | 0.083 | 0.118 | 0.108 | 0.085 | 0.114 | 0.132 | 0.101 | 0.06 | 0.101 | 0.104 | 0.085 | 0.089 | 0.105 | 0.126 | 0.09 | 0.1 | 0.12 | 0.149 | 0.099 | 0.106 | 0.131 | 0.13 | 0.13 |
EPS
| -0.002 | 0.09 | 0.09 | 0.004 | -0.011 | 0.086 | 0.12 | 0.16 | 0.15 | 0.2 | 0.16 | 0.15 | 0.13 | 0.16 | 0.1 | 0.14 | 0.1 | 0.25 | 0.099 | 0.11 | 0.099 | 0.2 | 0.088 | 0.14 | 0.088 | 0.2 | 0.081 | 0.15 | 0.084 | 0.21 | 0.076 | 0.14 | 0.09 | 0.075 | 0.075 |
EPS Diluted
| -0.002 | 0.09 | 0.09 | 0.004 | -0.011 | 0.086 | 0.12 | 0.16 | 0.15 | 0.2 | 0.16 | 0.15 | 0.13 | 0.16 | 0.1 | 0.14 | 0.1 | 0.25 | 0.099 | 0.11 | 0.099 | 0.2 | 0.088 | 0.14 | 0.088 | 0.2 | 0.081 | 0.15 | 0.084 | 0.21 | 0.076 | 0.14 | 0.09 | 0.075 | 0.075 |
EBITDA
| 0.568 | 25.001 | 39.965 | 44.651 | -1.915 | 44.212 | 57.206 | 92.604 | 38.528 | 46.649 | 42.539 | 59.382 | 26.875 | 29.205 | 42.402 | 30.123 | 38.524 | 48.873 | 39.003 | 19.044 | 40.21 | 42.542 | 36.213 | 32.125 | 33.369 | 37.568 | 22.497 | -238.569 | 114.624 | 37.149 | 21.359 | -198.517 | 105.546 | 21.585 | 21.585 |
EBITDA Ratio
| 0.002 | 0.086 | 0.131 | 0.129 | -0.007 | 0.149 | 0.159 | 0.244 | 0.116 | 0.139 | 0.132 | 0.181 | 0.093 | 0.117 | 0.131 | 0.102 | 0.127 | 0.145 | 0.123 | 0.056 | 0.122 | 0.122 | 0.106 | 0.11 | 0.122 | 0.147 | 0.101 | -1.085 | 0.614 | 0.199 | 0.115 | -1.118 | 0.626 | 0.153 | 0.153 |